Literature DB >> 11156692

The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling.

H Solberg1, M Ploug, G Høyer-Hansen, B S Nielsen, L R Lund.   

Abstract

uPAR is a cellular receptor for urokinase plasminogen activator, an enzyme involved in extracellular matrix degradation during processes involving tissue remodeling. We have expressed a recombinant soluble form of murine uPAR and raised rabbit polyclonal antibodies to study the expression of uPAR by immunohistochemistry. The immunohistochemical localization of uPAR was determined in normal mouse organs and in tumors formed by the highly metastatic Lewis lung carcinoma. uPAR immunoreactivity was found in the lungs, kidneys, and spleen, and in endothelial cells in the uterus, urinary bladder, thymus, heart, liver, and testis. No uPAR immunoreactivity was detected in muscle. In general, strong uPAR immunoreactivity was observed in organs undergoing extensive tissue remodeling, as exemplified by trophoblast cells in placenta, and in migrating, but not resting, keratinocytes at the edge of incisional wounds. Staining was not detected in any tissue sections derived from uPAR-deficient mice, thus confirming the specificity of the immunohistochemical staining of uPAR in normal mouse tissues. In Lewis lung carcinoma, uPAR immunoreactivity was found in the tumor cells of the primary tumor and in lung metastases. (J Histochem Cytochem 49:237-246, 2001)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156692     DOI: 10.1177/002215540104900211

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  35 in total

1.  Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.

Authors:  Sai Duriseti; David H Goetz; Daniel R Hostetter; Aaron M LeBeau; Ying Wei; Charles S Craik
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

2.  Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.

Authors:  Lily Yang; Zehong Cao; Hari Krishna Sajja; Hui Mao; Liya Wang; Huaying Geng; Hengyi Xu; Tieshan Jiang; William C Wood; Shuming Nie; Y Andrew Wang
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

3.  Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.

Authors:  Andrew S Gilder; Karra A Jones; Jingjing Hu; Lei Wang; Clark C Chen; Bob S Carter; Steven L Gonias
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

4.  Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.

Authors:  Kasper Almholt; Ole Didrik Lærum; Boye Schnack Nielsen; Ida Katrine Lund; Leif Røge Lund; John Rømer; Annika Jögi
Journal:  Clin Exp Metastasis       Date:  2015-06-04       Impact factor: 5.150

5.  Small-molecule inhibition of the uPAR·uPA interaction: synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis.

Authors:  Timmy Mani; Fang Wang; William Eric Knabe; Anthony L Sinn; May Khanna; Inha Jo; George E Sandusky; George W Sledge; David R Jones; Rajesh Khanna; Karen E Pollok; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2013-01-09       Impact factor: 3.641

Review 6.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

Review 7.  Role of mesenchymal stem cell-derived fibrinolytic factor in tissue regeneration and cancer progression.

Authors:  Beate Heissig; Douaa Dhahri; Salita Eiamboonsert; Yousef Salama; Hiroshi Shimazu; Shinya Munakata; Koichi Hattori
Journal:  Cell Mol Life Sci       Date:  2015-09-09       Impact factor: 9.261

8.  Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.

Authors:  Lily Yang; Hui Mao; Zehong Cao; Y Andrew Wang; Xianghong Peng; Xiaoxia Wang; Hari K Sajja; Liya Wang; Hongwei Duan; Chunchun Ni; Charles A Staley; William C Wood; Xiaohu Gao; Shuming Nie
Journal:  Gastroenterology       Date:  2009-01-14       Impact factor: 22.682

9.  Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.

Authors:  Heng Wang; John Hicks; Parham Khanbolooki; Sun-Jin Kim; Chunhong Yan; Yao Wang; Douglas Boyd
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.

Authors:  Tariq U Azam; Husam R Shadid; Pennelope Blakely; Patrick O'Hayer; Hanna Berlin; Michael Pan; Peiyao Zhao; Lili Zhao; Subramaniam Pennathur; Rodica Pop-Busui; Izzet Altintas; Jens Tingleff; Marius A Stauning; Ove Andersen; Maria-Evangelia Adami; Nicky Solomonidi; Maria Tsilika; Pinkus Tober-Lau; Eleni Arnaoutoglou; Verena Keitel; Frank Tacke; Athanasios Chalkias; Sven H Loosen; Evangelos J Giamarellos-Bourboulis; Jesper Eugen-Olsen; Jochen Reiser; Salim S Hayek
Journal:  J Am Soc Nephrol       Date:  2020-09-22       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.